This site is intended for healthcare professionals
Login
Register
Medical education
Specialty
News
Congresses
Search
Menu
Home
Medical education
Specialty
News
Congresses
Home
/
Medical education
/
Antiplatelet therapy in ACS – Overview
/
Videos
/
Should another prospective randomised trial be per...
Should another prospective randomised trial be performed for ticagrelor versus prasugrel?
Antiplatelet therapy in ACS – Overview
Antiplatelet therapy in ACS
ACS Patient Focus
Expert Opinion
ESC 2022 Highlights
Bookmark
Bookmarked
previous video
Roundtable Discussion: Closing remarks
next video
Controversies on choice of P2Y12 inhibitor: Are the recommendations justifiable?
Top